发明名称 |
Pharmaceutical formulation of apomorphine for buccal administration |
摘要 |
The present invention provides a kit comprising, in separate compartments of a container, the following components (a) and (b): (a) a combination of apomorphine or a pharmaceutically acceptable acid addition salt thereof and a pharmaceutically acceptable excipient or carrier; and (b) a solution which comprises a diluent and a pH modifying agent; the components being presented such that they can be combined at the point of use into a formulation which is adjusted to a pH ranging from mildly acidic to alkaline and which is suitable for buccal administration. The formulation is useful in treating Parkinson's disease and in promoting sexual function. |
申请公布号 |
US8772309(B2) |
申请公布日期 |
2014.07.08 |
申请号 |
US201213669148 |
申请日期 |
2012.11.05 |
申请人 |
Amarin Pharmaceuticals Ireland Limited |
发明人 |
Clarke Anthony |
分类号 |
A01N43/42;A61K31/44 |
主分类号 |
A01N43/42 |
代理机构 |
Dickinson Wright PLLC |
代理人 |
Dickinson Wright PLLC |
主权项 |
1. A method of buccally administering an apomorphine composition to a patient in need thereof, comprising:
(a) at the time of administration, adding a diluent and a pH modifying agent to an apomorphine composition to form a liquid composition comprising a pharmaceutically effective amount of apomorphine or a pharmaceutically acceptable acid addition salt thereof and a pharmaceutically acceptable excipient or carrier and to adjust the pH of the liquid composition to a pH ranging from mildly acidic to alkaline, thereby forming a pH adjusted liquid composition; and then (b) introducing the resulting pH adjusted liquid composition to the mouth of a patient in need thereof, thereby buccally administering a pharmaceutically effective amount of apomorphine or a pharmaceutically acceptable acid salt thereof. |
地址 |
Ballsbridge IE |